BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1435613)

  • 1. Dose distributions produced by shielded applicators using 241Am for intracavitary irradiation of tumors in the vagina.
    Muench PJ; Nath R
    Med Phys; 1992; 19(5):1299-306. PubMed ID: 1435613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an 241Am applicator for intracavitary irradiation of gynecologic cancers.
    Nath R; Peschel RE; Park CH; Fischer JJ
    Int J Radiat Oncol Biol Phys; 1988 May; 14(5):969-78. PubMed ID: 3360663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dose computation model for 241Am vaginal applicators including the source-to-source shielding effects.
    Nath R; Park CH; King CR; Muench P
    Med Phys; 1990; 17(5):833-42. PubMed ID: 2233569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetry studies on prototype 241Am sources for brachytherapy.
    Nath R; Gray L
    Int J Radiat Oncol Biol Phys; 1987 Jun; 13(6):897-905. PubMed ID: 3583861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a shielded 241Am applicator for continuous low dose rate irradiation of rat rectum.
    Nath R; Rockwell S; King CR; Bongiorni P; Kelley M; Carter D
    Int J Radiat Oncol Biol Phys; 1992; 23(1):175-81. PubMed ID: 1572814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose distributions around cylindrical 241Am sources for a clinical intracavitary applicator.
    Nath R; Gray L; Park CH
    Med Phys; 1987; 14(5):809-17. PubMed ID: 3683310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A monte carlo dosimetry study of vaginal 192Ir brachytherapy applications with a shielded cylindrical applicator set.
    Lymperopoulou G; Pantelis E; Papagiannis P; Rozaki-Mavrouli H; Sakelliou L; Baltas D; Karaiskos P
    Med Phys; 2004 Nov; 31(11):3080-6. PubMed ID: 15587661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accounting for high Z shields in brachytherapy using collapsed cone superposition for scatter dose calculation.
    Tedgren AK; Ahnesjö A
    Med Phys; 2003 Aug; 30(8):2206-17. PubMed ID: 12945986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose distributions produced by a shielded vaginal cylinder using a high-activity iridium-192 source.
    Waterman FM; Holcomb DE
    Med Phys; 1994 Jan; 21(1):101-6. PubMed ID: 8164574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an 241Am applicator for continuous low-dose-rate irradiation of the rat sarcoma BA1112.
    Nath R; Martin DF; Park CH; Rockwell S; Fischer JJ
    Int J Radiat Oncol Biol Phys; 1987 Dec; 13(12):1883-92. PubMed ID: 3679927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the validity of the superposition principle in dose calculations for intracavitary implants with shielded vaginal colpostats.
    Markman J; Williamson JF; Dempsey JF; Low DA
    Med Phys; 2001 Feb; 28(2):147-55. PubMed ID: 11243337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of prototype shielded cervical intracavitary brachytherapy applicators compatible with CT and MR imaging.
    Price MJ; Jackson EF; Gifford KA; Eifel PJ; Mourtada F
    Med Phys; 2009 Dec; 36(12):5515-24. PubMed ID: 20095264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric accuracy of a deterministic radiation transport based 192Ir brachytherapy treatment planning system. Part II: Monte Carlo and experimental verification of a multiple source dwell position plan employing a shielded applicator.
    Petrokokkinos L; Zourari K; Pantelis E; Moutsatsos A; Karaiskos P; Sakelliou L; Seimenis I; Georgiou E; Papagiannis P
    Med Phys; 2011 Apr; 38(4):1981-92. PubMed ID: 21626931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric analysis of a shielded applicator for nasopharyngeal carcinoma intracavitary brachytherapy: Monte Carlo calculation.
    Chen LX; Liu XW; You RA; Qian JY; Qi ZY; Deng XW; Tsao SY
    Med Phys; 2006 Mar; 33(3):761-9. PubMed ID: 16878578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement and calculation of heterogeneity correction factors for an Ir-192 high dose-rate brachytherapy source behind tungsten alloy and steel shields.
    Kirov AS; Williamson JF; Meigooni AS; Zhu Y
    Med Phys; 1996 Jun; 23(6):911-9. PubMed ID: 8798161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating dose distributions of high dose rate
    Aloraibi HA; Siavashpour Z; Ghorbani M; Abtahi M; Jassim H; Gholami S
    Appl Radiat Isot; 2024 Feb; 204():111124. PubMed ID: 38029638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-specific Monte Carlo dose calculations for high-dose-rate endorectal brachytherapy with shielded intracavitary applicator.
    Poon E; Williamson JF; Vuong T; Verhaegen F
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1259-66. PubMed ID: 18954720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of intracavitary applicators in 192Ir-HDR brachytherapy.
    Ye SJ; Brezovich IA; Shen S; Duan J; Popple RA; Pareek PN
    Med Phys; 2004 Jul; 31(7):2097-106. PubMed ID: 15305463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative biological effectiveness of 241Am relative to 192Ir for continuous low-dose-rate irradiation of BA1112 rat sarcomas.
    Morton J; Yabuki H; Porter EA; Rockwell S; Nath R
    Radiat Res; 1989 Sep; 119(3):478-88. PubMed ID: 2772139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple, inexpensive applicator for irradiation of localized areas of the vagina with intracavitary brachytherapy.
    Amdur RJ; Piontek R; Hadley VE; Conine FE; Sullivan S; Flaherty P
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):965-9. PubMed ID: 9128976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.